I won’t disagree with that. Additionally, the fact that BMSN is eligible for “Orphan Status” is even greater news. However the buyout is always an option, if the money is right of course.

Back to your comment though, it’s fascinating how BMSN has aligned the wheels for a tremendous opportunity backed with its science and team members.